On the selling side, ARK divested 38,338 shares of Palantir Technologies Inc (NYSE:PLTR) through its ARKK ETF, with the sale totaling $7,685,618. This marks a continuation of ARK’s recent reduction of ...
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Wednesday, October 29, ...
TipRanks on MSN
EXAS, GH, PLTR, SOFI: Cathie Wood Invests $5.5M in Exact Sciences, Trims Stakes in Guardant, Palantir, SoFi, and Other Big Names
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) revealed several key portfolio moves for Monday, October 20, 2025, ...
On the acquisition front, ARK’s ARKG ETF made a notable investment in Exact Sciences Corp (NASDAQ:EXAS), purchasing 90,731 shares worth around $5.56 million. This buy signals a growing interest from ...
Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.
StockStory.org on MSN
PacBio (PACB) Stock Is Up, What You Need To Know
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 4.4% in the afternoon session after the ...
In trading on Thursday, shares of the ARK Genomic Revolution ETF (Symbol: ARKG) crossed below their 200 day moving average of $23.99, changing hands as low as $23.95 per share. ARK Genomic Revolution ...
Imagine this: a hospital conference room, lights low, filled with decision-makers. A sales representative clicks through slides driven by Palantir Technologies’ (NASDAQ:PLTR) Foundry platform, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback